|
|
|
40
|
0211AK
|
ERTAPENEM 1G INJ (SLS/AHI)
|
ERTAPENEM
|
ERTAPENEM
|
1G VIAL
|
BQ
|
22.02
|
22.02
|
INJECTION
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120708
|
CARBAPENEMS
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
0212AR
|
IMIPENEM|CILASTATIN 500MG|500MG INJ (SLS) CILASTATIN|IMIPENE (BQ)
|
CILASTATIN|IMIPENEM
|
IMIPENEM|CILASTATIN
|
500MG VIAL
|
BQ
|
27.56
|
27.5638
|
VIAL
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120708
|
CARBAPENEMS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
CARBAPENEMS
|
|
|
|
|
41
|
0603D
|
FLUOROURACIL 50MG/ML INJ (SLS (BQ)
|
FLUOROURACIL
|
FLUOROURACIL
|
10ML
|
BQ
|
18.67
|
18.6749
|
VIAL
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
0603D
|
FLUOROURACIL 50MG/ML INJ (SLS
|
FLUOROURACIL
|
FLUOROURACIL
|
10ML
|
BQ
|
3.43
|
3.43
|
VIAL
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0621B
|
MERCAPTOPURINE 50MG TAB (SLS/AHI)
|
MERCAPTOPURINE
|
MERCAPTOPURINE
|
30'S
|
A
|
45.64
|
1.52
|
TABLET
|
60
|
TAB
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0621B
|
MERCAPTOPURINE 50MG TAB (SLS)
|
MERCAPTOPURINE
|
MERCAPTOPURINE
|
30'S
|
A
|
45.64
|
1.5214
|
TAB
|
60
|
BOX
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
0621B
|
MERCAPTOPURINE 50MG TAB (SLS)
|
MERCAPTOPURINE
|
MERCAPTOPURINE
|
30'S
|
A
|
45.64
|
1.52
|
TAB
|
60
|
BLIS
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0702C
|
PYRIDOSTIGMINE 60MG TAB (SLS/AHI)
|
PYRIDOSTIGMINE
|
PYRIDOSTIGMINE
|
50'S
|
A
|
31.10
|
0.62
|
TABLET
|
180
|
TAB
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
0801P
|
DOPAMINE 40MG/ML INJ (SLS/AHI)
|
DOPAMINE
|
DOPAMINE
|
25X5ML
|
B
|
35.47
|
1.42
|
INJECTION
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
0801P
|
DOPAMINE 40MG/ML INJ (SLS) (B)
|
DOPAMINE
|
DOPAMINE
|
25X5ML
|
B
|
40.37
|
1.6147
|
VIAL
|
0
|
BOX
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
BETA ADRENERGIC AGONIST
|
|
|
|
|
42
|
0801P
|
DOPAMINE 40MG/ML INJ (SLS)
|
DOPAMINE
|
DOPAMINE
|
25X5ML
|
BQ
|
51.38
|
2.06
|
VIAL
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2026-04-01
|
|
|
IV
|
0
|
BETA ADRENERGIC AGONIST
|
|
|
|
|
40
|
08234
|
ISOLIN 2MG/ML INJ (SLS/AHI) ISOPRENALINE
|
ISOPRENALINE
|
ISOLIN
|
5X1ML
|
BQ
|
37.92
|
7.58
|
INJECTION
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
08234
|
ISOLIN 2MG/ML INJ (SLS) ISOPRENALINE (BQ)
|
ISOPRENALINE
|
ISOLIN
|
5X1ML
|
BQ
|
37.92
|
7.5841
|
VIAL
|
1
|
BOX
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
BETA ADRENERGIC AGONIST
|
|
|
|
|
42
|
08234
|
ISOLIN 2MG/ML INJ (SLS) ISOPRENALINE
|
ISOPRENALINE
|
ISOLIN
|
5X1ML
|
BQ
|
38.17
|
7.63
|
VIAL
|
1
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121208
|
BETA ADRENERGIC AGONIST
|
2026-04-01
|
|
|
IV
|
0
|
BETA ADRENERGIC AGONIST
|
|
|
|
|
40
|
0951L
|
SUXAMETHONIUM 50MG/ML INJ (SLS/AHI)
|
SUXAMETHONIUM
|
SUXAMETHONIUM
|
10X10ML
|
B
|
43.11
|
4.31
|
INJECTION
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
10415
|
PROTAMINE SULPHATE 10MG/ML INJ (SLS/AHI)
|
PROTAMINE SULPHATE
|
PROTAMINE SULPHATE
|
25X5ML
|
B
|
235.27
|
9.41
|
INJECTION
|
0
|
AMP
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
202808
|
ANTIHEPARIN
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
10415
|
PROTAMINE SULPHATE 10MG/ML INJ (SLS) (B)
|
PROTAMINE SULPHATE
|
PROTAMINE SULPHATE
|
25X5ML
|
B
|
235.27
|
9.4108
|
AMP
|
20
|
BOX
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
202808
|
ANTIHEPARIN
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTIHEPARIN
|
|
|
|
|
40
|
10518
|
AMINOCAPROIC ACID 250MG/ML INJ (SLS/AHI)
|
AMINOCAPROIC ACID
|
AMINOCAPROIC ACID
|
20ML
|
BQ
|
20.09
|
20.09
|
INJECTION
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
202816
|
HEMOSTATICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
10518
|
AMINOCAPROIC ACID 250MG/ML INJ (SLS (BQ)
|
AMINOCAPROIC ACID
|
AMINOCAPROIC ACID
|
20ML
|
BQ
|
20.2
|
20.1971
|
VIAL
|
10
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
202816
|
HEMOSTATICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
HEMOSTATICS
|
|
|
|
|
42
|
10518
|
AMINOCAPROIC ACID 250MG/ML INJ (SLS
|
AMINOCAPROIC ACID
|
AMINOCAPROIC ACID
|
20ML
|
BQ
|
20.25
|
20.25
|
VIAL
|
10
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
202816
|
HEMOSTATICS
|
2026-04-01
|
|
|
IV
|
0
|
HEMOSTATICS
|
|
